Urinary incontinence suspender

By using the urinary incontinence suspension strap body of the human body's inabsorbent material and the absorbent layer of the absorbent material is built into the urinary incontinence suspension strap, combining the mesh-like structure and the bioactive factor protective layer, the problem of foreign body feeling after implantation of the urinary incontinence suspension strap is solved. Reduced the occurrence of complications and maintained structural stability.

CN119055403APending Publication Date: 2024-12-03李惠珍
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411279037.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-12-07
Filing Date
2024-09-12
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing urinary incontinence suspension strap will bring a strong sense of foreign body to the human body after being implanted into the human body, resulting in complications such as contracture, chronic pain and sexual pain.

Method used

The suspender body is made of a non-absorbent material in the human body, and a hollow hole is installed inside it to cover the absorbing layer of the absorbable material in the human body. The suspender body is equipped with a grid-like structure, and an electrospinning layer or coated on both sides of the front and back. Bioactive factor protective coating to reduce foreign body sensation.

Benefits of technology

By reducing the contact area between the inabsorbent materials and tissues of the human body, reducing the sense of foreign body, reducing the occurrence of contractures, chronic pain and intercourse pain, and the absorption layer is filled with tissue to maintain structural stability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119055403A_ABST
    Figure CN119055403A_ABST
Patent Text Reader

Abstract

The invention discloses a urinary incontinence suspender, which belongs to the field of medical instruments, and comprises a suspender body made of a human body non-absorbable material, the suspender body is also provided with a hollow hole, and an absorption layer made of a human body absorbable material is covered in the hollow hole. After the urinary incontinence suspender is implanted into the human body, due to the fact that the absorbing layer made of the material capable of being absorbed by the human body is arranged in the suspender body, under the condition that the overall size of the suspender body is not changed, the contact area between the material capable of being absorbed by the human body and tissue is effectively reduced, and therefore foreign body sensation is reduced; the space where the absorption layer made of the human body absorbable material is located can be filled and occupied by the tissue, and therefore the stability of the original structure is continuously maintained.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of medical devices, and in particular to a urinary incontinence sling. Background Art

[0002] Urinary incontinence is not generally considered a disease, but rather a symptom or side effect of a medical condition. Known causes of male incontinence include prostate surgery, particularly total prostatectomy, head and spinal cord injuries or infections, certain toxins such as excessive alcohol consumption, certain medications such as sedatives, and certain diseases such as cancer, Parkinson's disease, and multiple sclerosis. Additionally, male incontinence may simply be due to the aging process or emotional pain. Female incontinence is caused by weakened and / or stretched pelvic muscles, which are associated with childbirth, pregnancy, trauma, previous surgery, and loss of estrogen.

[0003] Stress incontinence is the most common type of incontinence, where urine leakage occurs during a triggering event, such as sneezing, dancing, lifting heavy objects, or when the patient performs any type of exercise that puts pressure on the bladder. Urge incontinence occurs when the patient wants to urinate but cannot restrain until they reach the bathroom. Other types of incontinence include overflow incontinence, which occurs when the amount of urine exceeds the capacity of the patient's bladder, and functional incontinence, which occurs when the patient knows they need to urinate but cannot get to the bathroom quickly enough due to physical impairment or weakness.

[0004] To treat urinary incontinence, there are several options, such as behavioral techniques, such as biofeedback, bladder training, pelvic muscle exercises, and changes in the patient's diet and fluid intake. For the latter, eliminating or reducing certain types of substances, such as caffeine and alcohol, is known to help relieve incontinence. In addition, medications that help control urinary incontinence, such as dicyclomine (Benzyl), xanthate (URISPAs), hyoscyamine sulfate (ANASPAZ), imipramine (TOFRANIL), oxybutynin (DITROPAN), tolterodine (DETROL) and alanine (PRO-BANTHINE), phenylpropanolamine (DEXATRIM), and pseudoephedrine (SUDAFED), are also available.

[0005] Surgery can also be an option for treating male and female urinary incontinence, and urinary incontinence slings are produced as a result. For example, the Chinese invention patent with publication number CN115737194A provides an urinary incontinence sling and its application, wherein the urinary incontinence sling is composed of a surgical mesh sling, an anchor head and a puncture accessory, the surgical mesh sling is provided with a suspension section with equal width in the middle and traction sections with narrowed ends, and the anchor head is fixed to the end of the traction section on one side, and the puncture accessory is connected to the traction section on the other side, characterized in that: the anchor head is provided with an axially through column, wherein the upper section of the column is provided with a tapered column section with a gradually reduced outer diameter, the middle section is provided with an opening and a wing section extending in a direction opposite to the tapered column section, and the lower section is provided with a unilaterally opened binding section, the end of the traction section on one side is connected and fixed to the binding section, the anchor head is driven by the puncture tool to penetrate into the fascia tissue, and is clamped therein by the wing section, so as to stop the anchor head from returning along the original path of the puncture tool and assist in separating the anchor head from the puncture tool.

[0006] In this invention patent, after the sling is implanted in the human body, the surgical mesh sling part used to suspend the tissue will give the human body a strong foreign body sensation, thereby causing complications such as contracture, chronic pain, and sexual intercourse pain. Based on this, there is an urgent need for a urinary incontinence sling that can reduce the foreign body sensation. Summary of the invention

[0007] In view of the problem that the urinary incontinence sling in the prior art will give the human body a strong foreign body sensation after being implanted, the purpose of the present invention is to provide a urinary incontinence sling to at least partially solve the above problem.

[0008] To achieve the above object, the technical solution of the present invention is: A urinary incontinence sling comprises a sling body made of a material that is not absorbable by the human body. The sling body is also provided with hollow holes, and an absorbent layer made of a material that can be absorbed by the human body is covered in the hollow holes.

[0009] In a preferred embodiment, the non-absorbable material includes polypropylene, polytetrafluoroethylene, polyester, acrylic resin or polyacrylamide, and the absorbable material includes polylactic acid, polyhydroxyacetate, poly-ε-caprolactone, polyhydroxybutyrate or their block copolymers.

[0010] In a preferred embodiment, the sling body is configured in a grid-like structure.

[0011] In a preferred embodiment, the sling body is in the shape of an elongated strip.

[0012] In a preferred embodiment, the absorption layer is located at the center of the sling body, and the sling body is symmetrically structured.

[0013] In a preferred embodiment, the width of the sling body is 10-12 mm.

[0014] In a preferred embodiment, both the front and back sides of the sling body are coated with electrospun layers made of human body absorbable material.

[0015] In a preferred embodiment, both the front and back sides of the sling body are coated with a protective coating made of bioactive factors.

[0016] By adopting the above technical solution, the beneficial effect of the present invention is that in the urinary incontinence sling provided by the present invention, since the sling body is provided with an absorbent layer made of human body absorbable material inside, the area proportion of human body non-absorbable material will be reduced when the overall size of the sling body remains unchanged, so the contact area between human body non-absorbable material and tissue is effectively reduced, thereby reducing the foreign body sensation, thereby reducing the possibility of complications such as contracture, chronic pain, and sexual intercourse pain. When the urinary incontinence sling is implanted in the human body, the space where the absorbent layer made of human body absorbable material is located will be filled and occupied by tissue, thereby continuously maintaining the stability of the original structure. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] Figure 1 It is the front view of the present invention.

[0018] Figure 2 It is a structural schematic diagram of the present invention.

[0019] In the figure: 1-sling body, 2-absorption layer. DETAILED DESCRIPTION

[0020] The specific embodiments of the present invention are further described below in conjunction with the accompanying drawings. It should be noted that the description of these embodiments is used to help understand the present invention, but does not constitute a limitation of the present invention. In addition, the technical features involved in the various embodiments of the present invention described below can be combined with each other as long as they do not conflict with each other.

[0021] It should be noted that, in the description of the present invention, the directions or positional relationships indicated by the terms "up", "down", "left", "right", "front", "back", etc. are descriptions of the structure of the present invention based on the accompanying drawings, and are only for the convenience of describing the present invention, and do not indicate or imply that the device or element referred to must have a specific direction, be constructed and operated in a specific direction, and therefore cannot be understood as a limitation on the present invention.

[0022] The "first" and "second" in this technical solution are only used to distinguish the names of the same or similar structures, or corresponding structures with similar functions, and are not an arrangement of the importance of these structures, nor do they have a ranking, comparison of size, or other meanings.

[0023] In addition, unless otherwise clearly specified and limited, the terms "installation" and "connection" should be understood in a broad sense. For example, the connection can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection or an indirect connection through an intermediate medium, or it can be a connection between the two structures. For ordinary technicians in this field, the specific meanings of the above terms in the present invention can be understood based on the overall idea of ​​the present invention and the specific context of the present solution.

[0024] Example 1 like Figure 1-2 As shown, the embodiment of the present invention provides a urinary incontinence sling, including a sling body 1, which is in the form of a long strip of sheet structure, with a width of about 10-12 mm, and a length that can be configured in multiple sizes as needed. In addition, the sling body has a front-to-back, left-to-right, and front-to-back symmetrical shape, where "front-to-back" refers to Figure 1 The up and down direction of the content displayed, "left and right" refers to Figure 1 The left and right direction of the content shown, the front side refers to Figure 1 The side of the content shown is facing the viewer.

[0025] The sling body 1 is made entirely of a material that is not absorbable by the human body, such as polypropylene, polytetrafluoroethylene, polyester, acrylic resin or polyacrylamide.

[0026] A hollow hole is provided in the middle of the sling body 1, and the hollow hole is also configured in a long strip shape and parallel to the sling body 1, and the sling body 1 with the hollow hole is still symmetrical in front and back, left and right, and front and back. The hollow hole is covered with an absorbent layer 2 made of a human body absorbable material, such as polylactic acid, polyglycolic acid, poly-ε-caprolactone, polyhydroxybutyrate or its block copolymer.

[0027] The usage of the embodiment of the present invention is as follows: When the urinary incontinence sling provided in this embodiment is implanted in the human body for use, the sling body bends accordingly and is fixedly connected to the tissue through the two suspension layers 3. The support layer 2 serving as the "suspension area" is used to provide structural support to the posterior pelvic tissue.

[0028] In the urinary incontinence sling provided in this embodiment, since the absorption layer 2 is made of human body absorbable material, the area ratio of human body non-absorbable material will be reduced when the overall size of the urinary incontinence sling remains unchanged, and the corresponding contact area between human body non-absorbable material and tissue is also effectively reduced, thereby reducing the foreign body sensation, thereby reducing the possibility of complications such as contracture, chronic pain, and sexual intercourse pain. When the urinary incontinence sling is implanted in the human body, the space where the absorption layer 2 made of human body absorbable material is located will be filled and occupied by tissue, thereby continuously maintaining the stability of the original structure.

[0029] Example 2 The difference between the embodiment 1 and the embodiment 1 is that the sling body 1 is configured to be a grid structure, for example, woven, so that the sling body 1 has more gaps, which reduces the weight of the sling body 1 and reduces the contact area between the sling body 1 and the tissue, thereby reducing the foreign body sensation.

[0030] Example 3 The difference between this embodiment and the first embodiment is that in this embodiment, electrospun layers made of human body absorbable material are applied on both the front and back sides of the sling body 1 .

[0031] In this embodiment, the size and shape of the electrospun layer are adapted to the sling body 1, and the electrospun layer just completely covers the sling body 1, and the electrospun layer is provided with avoidance holes adapted to the absorbent layer 2 on the sling body 1, so that the sling body 1 is completely covered with human body absorbable material.

[0032] In this way, by providing the electrospinning layer, the friction between the sling body 1 and the tissue can be effectively reduced, and the tissue growth can be stimulated, thereby improving the bonding between the sling body and the tissue.

[0033] Example 4 The difference between this embodiment and the third embodiment is that in this embodiment, a protective coating composed of active factors is applied on both the front and back sides of the sling body 1 to replace the electrospun layer, thereby reducing rejection and inflammation.

[0034] Among them, common biologically active factors related to PFD (pelvic floor dysfunction) include estrogen and growth factors, such as basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), transforming growth factor β (TGF-β), etc.

[0035] The embodiments of the present invention are described in detail above with reference to the accompanying drawings, but the present invention is not limited to the described embodiments. For those skilled in the art, various changes, modifications, substitutions and variations of these embodiments are made without departing from the principles and spirit of the present invention, and still fall within the scope of protection of the present invention.

Claims

1. A sling for urinary incontinence, characterized in that: The sling comprises a sling body made of a material that is not absorbable by the human body. The sling body is also provided with hollow holes, and the hollow holes are covered with an absorption layer made of a material that can be absorbed by the human body.

2. The urinary incontinence sling according to claim 1, characterized in that: The human body non-absorbable material includes polypropylene, polytetrafluoroethylene, polyester, acrylic resin or polyacrylamide, and the human body absorbable material includes polylactic acid, polyglycolic acid ester, poly-ε-caprolactone, polyhydroxybutyrate or their block copolymers.

3. The urinary incontinence sling according to claim 1, characterized in that: The sling body is configured in a grid-like structure.

4. The urinary incontinence sling according to claim 1, characterized in that: The sling body is in the shape of an elongated strip.

5. The urinary incontinence sling according to claim 4, characterized in that: The absorption layer is located at the center of the sling body, and the sling body is symmetrically structured.

6. The urinary incontinence sling according to claim 4, characterized in that: The width of the sling body is 10-12 mm.

7. The urinary incontinence sling according to claim 1, characterized in that: The front and back sides of the sling body are both coated with electrospun layers made of human body absorbable material.

8. The urinary incontinence sling according to claim 1, characterized in that: The front and back sides of the sling body are coated with a protective coating made of bioactive factors.